Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Autologous SVF Derived MSC in Kidney Transplantation From DCD
NCT02492490Phase 2Unknown
- Sponsor
- 900th Hospital of Joint Logistics Support Force of PLA
- Start
- Dec 2014
- Primary completion
- Nov 2016
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in uremia (2 arms), sponsored by 900th Hospital of Joint Logistics Support Force of PLA. Primary endpoint: Reducing the dosage of calcineurin inhibitor (CNI) by 30% at 1 year. Status: unknown.
02
Conditions
uremia
Beyond the preview
Go deeper on NCT02492490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492490.